Загрузка...
Retrospective study of adjuvant icotinib in postoperative lung cancer patients harboring epidermal growth factor receptor mutations
BACKGROUND: Epidermal growth factor receptor (EGFR) mutations occur in about 50% of Asian patients with non‐small cell lung cancer (NSCLC). Patients with advanced NSCLC and EGFR mutations derive clinical benefit from treatment with EGFR‐tyrosine kinase inhibitors (TKIs). This study assessed the effi...
Сохранить в:
| Опубликовано в: : | Thorac Cancer |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons Australia, Ltd
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5130296/ https://ncbi.nlm.nih.gov/pubmed/27766784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12365 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|